The prevalence, penetrance, and expressivity of etiologicIRF6variants in orofacial clefts patients from sub‐Saharan Africa
Open Access
- 12 January 2017
- journal article
- research article
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 5 (2) , 164-171
Abstract
Background: Orofacial clefts are congenital malformations of the orofacial region, with a global incidence of one per 700 live births. Interferon Regulatory Factor 6 (IRF6) (OMIM:607199) gene has been associated with the etiology of both syndromic and nonsyndromic orofacial clefts. The aim of this study was to show evidence of potentially pathogenic variants inIRF6in orofacial clefts cohorts from Africa.Methods: We carried out Sanger Sequencing onDNAfrom 184 patients with nonsyndromic orofacial clefts and 80 individuals with multiple congenital anomalies that presented with orofacial clefts. We sequenced all the nine exons ofIRF6as well as the 5′ and 3′ untranslated regions. In our analyses pipeline, we used various bioinformatics tools to detect and describe the potentially etiologic variants.Results: We observed that potentially etiologic exonic and splice site variants were nonrandomly distributed among the nine exons ofIRF6, with 92% of these variants occurring in exons 4 and 7. Novel variants were also observed in both nonsyndromic orofacial clefts (p.Glu69Lys, p.Asn185Thr, c.175‐2A>C and c.1060+26C>T) and multiple congenital anomalies (p.Gly65Val, p.Lys320Asn and c.379+1G>T) patients. Our data also show evidence of compound heterozygotes that may modify phenotypes that emanate fromIRF6variants.Conclusions: This study demonstrates that exons 4 and 7 ofIRF6are mutational ‘hotspots’ in our cohort and thatIRF6mutants‐induced orofacial clefts may be prevalent in the Africa population, however, with variable penetrance and expressivity. These observations are relevant for detection of high‐risk families as well as genetic counseling. In conclusion, we have shown that there may be a need to combine both molecular and clinical evidence in the grouping of orofacial clefts into syndromic and nonsyndromic forms.Keywords
Funding Information
- National Institute of Dental and Craniofacial Research (DE022378‐03)
- Robert Wood Johnson Foundation (72429)
- National Institutes of Health (DE‐08559, DE‐016148)
This publication has 27 references indexed in Scilit:
- Disease-associated mutations in IRF6 and RIPK4 dysregulate their signalling functionsCellular Signalling, 2015
- Rare functional variants in genome–wide association identified candidate genes for nonsyndromic clefts in the African populationAmerican Journal of Medical Genetics Part A, 2014
- Novel IRF6 mutations in families with Van Der Woude syndrome and popliteal pterygium syndrome from sub‐Saharan AfricaMolecular Genetics & Genomic Medicine, 2014
- An etiologic regulatory mutation in IRF6 with loss- and gain-of-function effectsHuman Molecular Genetics, 2014
- Novel IRF6 mutations in Honduran Van Der Woude syndrome patientsMolecular Medicine Reports, 2011
- Cleft lip and palate: understanding genetic and environmental influencesNature Reviews Genetics, 2011
- IRF6 Screening of Syndromic and a priori Non-Syndromic Cleft Lip and Palate Patients: Identification of a New Type of Minor VWS SignMolecular Syndromology, 2010
- Prevalence and nonrandom distribution of exonic mutations in interferon regulatory factor 6 in 307 families with Van der Woude syndrome and 37 families with popliteal pterygium syndromeGenetics in Medicine, 2009
- Six families with van der Woude and/or popliteal pterygium syndrome: all with a mutation in the IRF6 geneJournal of Medical Genetics, 2004
- Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromesNature Genetics, 2002